Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease
about
Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung DiseaseRole for phospholipid acyl chains and cholesterol in pulmonary infections and inflammationAtherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureDry powder formulation of simvastatin.Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells.The role of the liver X receptor in chronic obstructive pulmonary disease.25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome.Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.Year in review 2012: asthma and chronic obstructive pulmonary disease.25-Hydroxycholesterol impairs endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase.Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells.RNA-sequencing analysis of lung primary fibroblast response to eosinophil-degranulation products predicts downstream effects on inflammation, tissue remodeling and lipid metabolism.Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products.Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary disease.
P2860
Q28383936-A8E93B79-E207-49CC-8549-86869135FDBEQ28391857-0905E8D2-235A-42A1-8F8E-25261E0B53EBQ35127516-F8C419D6-536D-4F98-A75E-0FFEA723D316Q35269057-74F8D2F8-CEC1-459F-9FD1-7D25713F5094Q35735440-7EB9D94C-8453-4BE5-83AE-9E774C1AA1A3Q37367993-A4F27322-4356-4B0A-AEDA-7EA167DFE455Q37389923-3E143E1E-2BF9-4016-8762-A14D25177B6BQ37734257-39E7CBBD-2DBD-4ADF-95DD-DB7EF07FDD6EQ38073789-C0204075-128A-4363-803B-A03496F47B08Q39417123-AAF0C8B7-37D8-42D4-83B5-96845371E893Q40835741-DE8A6D8D-A4C1-4B39-BB6C-6E2F8BA049FBQ41868351-B2DB725E-85D7-4978-829F-C29638CF984FQ47161265-9AD53D79-E6A4-4C66-9C9D-F25D4BBBBE37Q49346082-10577433-23CE-41FC-B8C3-F3B3FBC847E3Q52576641-4F03CEBE-AA4C-4C11-8B47-49DE18B94040
P2860
Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease
description
im März 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2012
@uk
name
Increased 25-hydroxycholestero ...... obstructive pulmonary disease
@en
Increased 25-hydroxycholestero ...... obstructive pulmonary disease
@nl
type
label
Increased 25-hydroxycholestero ...... obstructive pulmonary disease
@en
Increased 25-hydroxycholestero ...... obstructive pulmonary disease
@nl
prefLabel
Increased 25-hydroxycholestero ...... obstructive pulmonary disease
@en
Increased 25-hydroxycholestero ...... obstructive pulmonary disease
@nl
P2093
P2860
P50
P1433
P1476
Increased 25-hydroxycholestero ...... obstructive pulmonary disease
@en
P2093
AKIRA KOARAI
HISATOSHI SUGIURA
KAZUTO MATSUNAGA
KEIICHIRO AKAMATSU
MAKOTO FURUSAWA
MASAKAZU ICHINOSE
MASASHI YAMASAKI
TOMOHIRO ICHIKAWA
TSUNAHIKO HIRANO
YUMIKO UNO
P2860
P304
P356
10.1111/J.1440-1843.2012.02136.X
P577
2012-03-23T00:00:00Z